Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Supplement—December 2022
SUPPLEMENT ISSUE
Surveillance

Contribution of PEPFAR-Supported HIV and TB Molecular Diagnostic Networks to COVID-19 Testing Preparedness in 16 Countries

Erin Rottinghaus RomanoComments to Author , Katrina Sleeman, Patricia Hall-Eidson, Clement Zeh, Ravikiran Bhairavabhotla, Guoqing Zhang, Amitabh Adhikari, George Alemnji, Yolanda Rebello Cardo, Ana Pinheiro, Barbara Pocongo, Laura T. Eno, Judith D. Shang, Clement B. Ndongmo, Hilda Rosario, Orquidea Moreno, Lucia Aurora De La Cruz De León, Peter Fonjungo, Constantin Kabwe, Steve Ahuke-Mundeke, Dan Gama, Sindisiwe Dlamini, Gugu Maphalala, Tefsay Abreha, Anne Purfield, Yared Tedla Gebrehiwot, Daniel Melese Desalegn, Frank Basiye, Jane Mwangi, Nancy Bowen, Yohannes Mengistu, Shirley Lecher, Elizabeth Kampira, Muluken Kaba, Joseph Bitilinyu-Bangoh, Gillian Masamha, Sofia Omar Viegas, R. Suzanne Beard, Gerhard van Rooyen, Andreas N. Shiningavamwe, McPaul I.J, Nnaemeka C. Iriemenam, Nwando Mba, Catherine Okoi, Joel Katoro, Dennis L Kenyi, Bior K. Bior, Christina Mwangi, Susan Nabadda, Pontiano Kaleebu, Samuel L. Yingst, Prisca Chikwanda, Levi Veri, Raivi Simbi, and Heather Alexander
Author affiliations: US Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA (E. Rottinghaus Romano, K. Sleeman, P. Hall-Eidson, C. Zeh, R. Bhairavabhotla, G. Zhang, A. Adhikari, H. Alexander); Office of the Global AIDS Coordinator, Washington, DC, USA (G. Alemnji); CDC Center for Global Health, Luanda, Angola (Y. Rebello Cardo); African Field Epidemiology Network, Luanda (A. Pinheiro); Instituto Nacional de Luta Contra SIDA, Luanda (B. Pocongo); CDC Center for Global Health, Yaoundé, Cameroon (L.T. Eno, J.D. Shang, C.B. Ndongmo); CDC Center for Global Health, Santo Domingo, Dominican Republic (H. Rosario); Laboratorio Nacional de Salud Pública Dr. Fernando A. Defilló, Santa Domingo (O. Moreno, L.A. De La Cruz De León); CDC Center for Global Health, Kinshasa, Democratic Republic of the Congo (P. Fonjungo, C. Kabwe); Institut National de Recherche Biomédicale, Kinshasa (S. Ahuke-Mundeke); CDC Center for Global Health, Mbabane, Eswatini (D. Gama); Ministry of Health Mbabane National Reference Laboratory, Mbabane (S. Dlamini, G. Maphalala); Columbia University Mailman School of Public Health International Center for AIDS Care and Treatment Programs, Mbabane (T. Abreha); CDC Center for Global Health, Addis Ababa, Ethiopia (A. Purfield, Y.T Gebrehiwot); Ethiopian Public Health Institute, Addis Ababa (D.M. Desalegn); CDC Center for Global Health, Nairobi, Kenya (F. Basiye, J. Mwangi); National Public Health Reference Laboratories, Nairobi (N. Bowen); CDC Center for Global Health, Maseru, Lesotho (Y. Mengistu, S. Lecher); CDC Center for Global Health, Lilongwe, Malawi (E. Kampira, M. Kaba); Ministry of Health Technical Support Services, Lilongwe (J. Bitilinyu-Bangoh); CDC Center for Global Health, Maputo, Mozambique (G. Masamha); Ministério da Saúde Instituto Nacional de Saúde, Maputo (S. Omar Viegas); CDC Center for Global Health, Windhoek, Namibia (R.S. Beard); Namibia Institute of Pathology Limited, Windhoek (G. van Rooyen, A.N. Shiningavamwe); CDC Center for Global Health, Abuja, Nigeria (M.I.J. Okoye, N.C. Iriemenam); Nigeria Centre for Disease Control, Abuja (N. Mba, C. Okoi); CDC Center for Global Health, Juba, South Sudan (J. Katoro, D.L. Kenyi); Ministry of Health Public Health Emergency Operations Center, Juba (B.K. Bior); CDC Center for Global Health, Kampala, Uganda (C. Mwangi); Ministry of Health National Health Laboratories and Diagnostic Services, Kampala, Uganda (S. Nabadda); Uganda Virus Research Institute, Entebbe, Uganda (P. Kaleebu); CDC Center for Global Health, Lusaka, Zambia (S.L. Yingst); CDC Center for Global Health, Harare, Zimbabwe (P. Chikwanda); Biomedical Research and Training Institute, Harare (L. Veri); Zimbabwe Ministry of Health and Child Care, Harare (R. Simbi)

Main Article

Table 1

Types of PEPFAR-supported laboratory systems used by 16 countries in their response to the COVID-19 pandemic, April 1, 2020–March 31, 2021*

Country Centralized resources Decentralized resources Laboratory information system
No. (%) countries implementing
16 (100)
16 (100)
11 (73)
Eswatini
Kenya
Lesotho
Malawi
Mozambique
South Sudan
Uganda
Zambia
Nigeria
Namibia
Zimbabwe
Angola No data
Cameroon
Dominican Republic
Ethiopia
Democratic Republic of the Congo

*PEPFAR, US President’s Emergency Plan for AIDS Relief; ✓, use of network component reported; –, network component was not used.

Main Article

Page created: October 05, 2022
Page updated: December 11, 2022
Page reviewed: December 11, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external